Cargando…
BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation
Identification of novel targets for triple-negative breast cancer (TNBC) is an urgent task as targeted therapies have increased the lifespans of Oestrogen Receptor (+)/ Progesterone Receptor (+) and HER(2+) cancer patients. Methods: genes involved in protein processing in the endoplasmic reticulum,...
Autores principales: | Fu, Wenyan, Sun, Hefen, Zhao, Yang, Chen, Mengting, Yang, Xueli, Liu, Yang, Jin, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771250/ https://www.ncbi.nlm.nih.gov/pubmed/31588230 http://dx.doi.org/10.7150/thno.35383 |
Ejemplares similares
-
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC
por: Liu, Yan, et al.
Publicado: (2019) -
Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells
por: Shin, Miyoung, et al.
Publicado: (2015) -
TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
por: Carroll, Natalie, et al.
Publicado: (2022) -
EGFR-dependent phosphorylation of leucine-rich repeat kinase LRRK1 is important for proper endosomal trafficking of EGFR
por: Ishikawa, Kouki, et al.
Publicado: (2012) -
MicroRNA-362-3p Inhibits Migration and Invasion via Targeting BCAP31 in Cervical Cancer
por: Yang, Shuya, et al.
Publicado: (2020)